• A
  • |
  • A
  • Text size

Personalized Medicine

Discoveries facilitated by the mapping of the human genome and rapid technological advances in genomic sequencing and interpretation are leading to medical innovations that will have a significant impact on the practice of medicine and delivery of health care services. As personalized medicine is integrated into the mainstream practice of medicine, many health care policy questions must be answered. This white paper is intended as a primer on key policy issues related to personalized medicine.

Learn more about genomics and clinical practice

Sign-on letter to FDA requesting withdrawal of proposed draft guidance on oversight of Laboratory Developed Tests, November 18, 2014

AMA letter to Energy and Commerce in response to its request for feedback on the 21st Century Cures initiative, September 26, 2014

AMA Statement for the Record re: 21st Century Cures: Examining the Regulation of Laboratory-Developed Tests, September 8, 2014.